AI assistant
Sending…
REGENXBIO Inc. — Director's Dealing 2018
May 30, 2018
32827_dirs_2018-05-30_790ea376-da51-4621-a5d3-c1382445f06b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENXBIO Inc. (RGNX)
CIK: 0001590877
Period of Report: 2018-05-25
Reporting Person: Tasse Daniel (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-05-25 | Stock Option (Right to Buy) | $49.45 | A | 12500.00 | Acquired | 2028-05-25 | Common Stock (12500.00) | Direct |
Footnotes
F1: The option will vest in 12 equal monthly installments following May 25, 2018.
More from REGENXBIO Inc.
Merger & Acquisition
2026
Jun 3
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Proxy Solicitation & Information Statement
2026
Apr 14
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Feb 10
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Jan 29